{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:32:31Z","timestamp":1792211551153,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3751,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.bbmt.2004.10.004","type":"journal-article","created":{"date-parts":[[2004,12,29]],"date-time":"2004-12-29T00:14:09Z","timestamp":1104279249000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease"],"prefix":"10.1016","volume":"11","author":[{"given":"Laura J.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Shizuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith E.","family":"Stockerl-Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monic J.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl G.","family":"Blume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Negrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson J.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2004.10.004_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood.V72.2.546.546","article-title":"Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease","volume":"72","author":"Sullivan","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.10.004_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V72.2.555.555","article-title":"Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease","volume":"72","author":"Sullivan","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.10.004_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood.V100.1.48","article-title":"Therapy for chronic graft-versus-host disease","volume":"100","author":"Koc","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.10.004_bib4","first-page":"5","article-title":"Traditional treatment of chronic graft-versus-host disease","volume":"12","author":"Flowers","year":"2002","journal-title":"Blood Marrow Transplant Rev."},{"key":"10.1016\/j.bbmt.2004.10.004_bib5","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1182\/blood.V97.5.1219","article-title":"Development of a prognostic model for grading chronic graft-versus-host disease","volume":"97","author":"Akpek","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.10.004_bib6","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood.V74.4.1428.1428","article-title":"Predictors of death from chronic graft-versus-host disease after bone marrow transplantation","volume":"74","author":"Wingard","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.10.004_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00005792-197601000-00003","article-title":"Glucocorticoid therapy","volume":"55","author":"Axelrod","year":"1976","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbmt.2004.10.004_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7164\/antibiotics.28.721","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle","volume":"28","author":"Vezina","year":"1975","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.bbmt.2004.10.004_bib9","series-title":"Hematopoietic Cell Transplantation","first-page":"176","article-title":"Pharmacology and use of immunosuppressive agents after hematopoietic cell transplantation","author":"Chao","year":"1999"},{"key":"10.1016\/j.bbmt.2004.10.004_bib10","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00007890-200110150-00001","article-title":"Rapamycin","volume":"72","author":"Kahan","year":"2001","journal-title":"Transplantation"},{"issue":"12 suppl","key":"10.1016\/j.bbmt.2004.10.004_bib11","first-page":"S105","article-title":"Improving tolerability of immunosuppressive regimens","volume":"72","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2004.10.004_bib12","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.4049\/jimmunol.151.10.5726","article-title":"Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome","volume":"151","author":"Blazar","year":"1993","journal-title":"J Immunol."},{"key":"10.1016\/j.bbmt.2004.10.004_bib13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/blood.V83.2.600.600","article-title":"Rapamycin, a potent inhibitor of T-cell function, prevents graft rejection in murine recipients of allogeneic T-cell-depleted donor marrow","volume":"83","author":"Blazar","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.10.004_bib14","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1182\/blood.V87.9.4001.bloodjournal8794001","article-title":"In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A","volume":"87","author":"Blazar","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.10.004_bib15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1083-8791(00)70062-0","article-title":"Graft-versus-host disease prevention by rapamycin","volume":"6","author":"Chen","year":"2000","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.10.004_bib16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med."},{"key":"10.1016\/j.bbmt.2004.10.004_bib17","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00007890-199810270-00013","article-title":"Immunosuppressive effects and safety of a sirolimus\/cyclosporine combination regimen for renal transplantation","volume":"66","author":"Kahan","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2004.10.004_bib18","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/00007890-199911270-00016","article-title":"Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts","volume":"68","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2004.10.004_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2004.10.004_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2004.10.004_bib21","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.10.004_bib22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1083-8791(00)70026-7","article-title":"Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease","volume":"6","author":"Carnevale-Schianca","year":"2000","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.10.004_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1053\/bbmt.2001.v7.pm11669216","article-title":"A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease","volume":"7","author":"Akpek","year":"2001","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.10.004_bib24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM199204163261604","article-title":"Thalidomide for the treatment of chronic graft-versus-host disease","volume":"326","author":"Vogelsang","year":"1992","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2004.10.004_bib25","doi-asserted-by":"crossref","first-page":"67a","DOI":"10.1016\/S1083-8791(03)80016-2","article-title":"Sirolimus (rapamycin) for treatment of steroid-refractory chronic graft versus host disease","volume":"9","author":"Couriel","year":"2003","journal-title":"Biology Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.10.004_bib26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ki.1996.28","article-title":"The side effect profile of sirolimus","volume":"49","author":"Murgia","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbmt.2004.10.004_bib27","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/00007890-200005270-00019","article-title":"Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients","volume":"69","author":"Hong","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2004.10.004_bib28","series-title":"Established Immunosuppressive Drugs","article-title":"Principles and practice of renal transplantation","author":"Kahan","year":"2000"},{"key":"10.1016\/j.bbmt.2004.10.004_bib29","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1097\/00007890-200112270-00010","article-title":"Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease","volume":"72","author":"Benito","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2004.10.004_bib30","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ki.1996.417","article-title":"Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506","volume":"50","author":"Andoh","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbmt.2004.10.004_bib31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199203000-00002","article-title":"The effect of rapamycin on kidney function in the Sprague-Dawley rat","volume":"53","author":"DiJoseph","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2004.10.004_bib32","first-page":"985","article-title":"A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients","volume":"28","author":"Brattstrom","year":"1996","journal-title":"Transplant Proc."},{"key":"10.1016\/j.bbmt.2004.10.004_bib33","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (rapamycin)-based therapy in human renal transplantation","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2004.10.004_bib34","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/00007890-200004150-00009","article-title":"Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients","volume":"69","author":"Kreis","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2004.10.004_bib35","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1517\/14656566.2.11.1903","article-title":"Sirolimus","volume":"2","author":"Kahan","year":"2001","journal-title":"Expert Opin Pharmacother."},{"key":"10.1016\/j.bbmt.2004.10.004_bib36","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1681\/ASN.V1251059","article-title":"Pharmacokinetic interactions augment toxicities of sirolimus\/cyclosporine combinations","volume":"12","author":"Podder","year":"2001","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.bbmt.2004.10.004_bib37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00007890-200203150-00017","article-title":"De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination","volume":"73","author":"Langer","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2004.10.004_bib38","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1182\/blood-2003-02-0489","article-title":"Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation","volume":"102","author":"Antin","year":"2003","journal-title":"Blood"},{"issue":"3 suppl","key":"10.1016\/j.bbmt.2004.10.004_bib39","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/S0041-1345(03)00351-8","article-title":"Ten years of sirolimus therapy for human renal transplantation","volume":"35","author":"Kahan","year":"2003","journal-title":"Transplant Proc."}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879104005257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879104005257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:22:23Z","timestamp":1761056543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879104005257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S1083879104005257"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2004.10.004","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2004.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}